Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanpra Synthesis

02 1Smilax Laboratories Limited

03 1Zhejiang Huahai Pharmaceutical Co., Ltd.

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cyanolosartan

CAS Number : 114772-55-3

End Use API :

About the Company : Sanpra Synthesis strongly believes that with its expertise and innovative pharmaceutical business background, it is aptly positioned for APIs and intermediates manufacturing and outsour...

blank

02

arrow
2024 ACI Convention
Not Confirmed

2-(4-{[2-Butyl-4-chloro-5- (hydroxymethyl)imidazol...

CAS Number : 114772-55-3

End Use API :

About the Company : Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for th...

blank

03

arrow
2024 ACI Convention
Not Confirmed

2-butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]...

CAS Number : 114772-55-3

End Use API :

About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceutical...

blank